Michael Zumer
Medical · Duncansville, PANPI 1144492786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $21,884 of the $27,803 with a category attached, or 78.7%. 29 manufacturers reported payments, led by AbbVie at 25.3% of the total. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,606 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Amgen$7K
- Pfizer$3K
- Johnson & Johnson$3K
- UCB, Inc.$1K
- AstraZeneca$1K
- plus $6K from 23 others
What the payments were for
- Consulting fees$1000%
- Speaking & faculty fees$5,43420%
- Travel & lodging$380%
- Food & beverage$21,88479%
- Education$3471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 611 | $7,029 |
| Amgen(2 entities) | 168 | $6,797 |
| Pfizer | 121 | $2,966 |
| Johnson & Johnson(2 entities) | 190 | $2,593 |
| UCB, Inc. | 104 | $1,218 |
| AstraZeneca(2 entities) | 53 | $1,166 |
| Novartis | 80 | $1,109 |
| GSK | 81 | $947 |
| Lilly USA, LLC | 45 | $813 |
| Sanofi | 14 | $662 |
| ANI Pharmaceuticals, Inc. | 22 | $442 |
| Mallinckrodt Hospital Products Inc. | 18 | $415 |
| E.r. Squibb & Sons, L.L.C. | 13 | $248 |
| Organon | 18 | $240 |
| Sobi, Inc | 13 | $232 |
| Aurinia Pharma U.S., Inc. | 8 | $152 |
| Radius Health, Inc. | 17 | $125 |
| Boehringer Ingelheim | 6 | $109 |
| Kyowa Kirin, Inc. | 4 | $105 |
| Cardinal Health 110 LLC | 1 | $100 |
| Fresenius Kabi USA, LLC | 3 | $73 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $67 |
| Ultragenyx Pharmaceutical Inc. | 4 | $56 |
| Novo Nordisk | 2 | $37 |
| Pacira Therapeutics, Inc. | 2 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Invivyd Inc | 1 | $22 |
| Swing Therapeutics, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,803 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 63 | $590,308 |
| Humira(Cf) PenAdalimumab | 68 | $571,897 |
| RinvoqUpadacitinib | 70 | $510,286 |
| Xeljanz XrTofacitinib Citrate | 29 | $179,340 |
| OtezlaApremilast | 30 | $145,495 |
| KevzaraSarilumab | 19 | $126,012 |
| Hydroxychloroquine Sulfate | 535 | $24,802 |
| MethotrexateMethotrexate Sodium | 596 | $17,019 |
| Leflunomide | 103 | $5,159 |
| SavellaMilnacipran Hcl | 11 | $5,151 |
| Duloxetine Hcl | 219 | $4,742 |
| Celecoxib | 171 | $4,452 |
| Cevimeline Hcl | 15 | $3,868 |
| Methylprednisolone | 163 | $2,398 |
| Gabapentin | 163 | $2,290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Savella | $7,029 | $515,43881 claims |
| AmgenOtezla | $6,797 | $145,49530 claims |
| SanofiKevzara | $662 | $126,01219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Duncansville
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.